140 related articles for article (PubMed ID: 38616463)
41. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
[TBL] [Abstract][Full Text] [Related]
42. Surveillance of prognostic risk factors in patients with SCCB using artificial intelligence: a retrospective study.
Zhanghuang C; Zhang Z; Wang J; Yao Z; Ji F; Wu C; Ma J; Yang Z; Xie Y; Tang H; Yan B
Sci Rep; 2023 May; 13(1):8727. PubMed ID: 37253772
[TBL] [Abstract][Full Text] [Related]
43. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
44. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
Xiao R; Liu C; He W; Ma L
Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
[TBL] [Abstract][Full Text] [Related]
45. Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
Ding Y; Jiang R; Chen Y; Jing J; Yang X; Wu X; Zhang X; Xu J; Xu P; LiuHuang SC; Lu Z
BMC Cancer; 2021 Apr; 21(1):420. PubMed ID: 33863315
[TBL] [Abstract][Full Text] [Related]
46. Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer.
Zhou Y; Lin C; Zhu L; Zhang R; Cheng L; Chang Y
Cancer Med; 2023 Feb; 12(3):2600-2613. PubMed ID: 35993499
[TBL] [Abstract][Full Text] [Related]
47. Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.
Shao Z; Li J; Liu Z; Bi S
Cancer Med; 2023 Apr; 12(8):9589-9603. PubMed ID: 36992547
[TBL] [Abstract][Full Text] [Related]
48. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
[TBL] [Abstract][Full Text] [Related]
49. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
50. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
51. Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.
Chen L; Chen Y; Shi H; Cai R
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17027-17037. PubMed ID: 37747524
[TBL] [Abstract][Full Text] [Related]
52. Development and Validation of Prognostic Nomograms Based on Lymph Node Ratio for Young Patients with Gastric Cancer: A SEER-Based Study.
Chen YR; Tian ZY; Wang MQ; Sun ML; Wu JZ; Wang XY
Technol Cancer Res Treat; 2023; 22():15330338231157923. PubMed ID: 37248609
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
Front Public Health; 2022; 10():969030. PubMed ID: 36203704
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of prognostic models for small cell lung cancer patients with liver metastasis: a SEER population-based study.
Li Q; Zhao Y; Xu Z; Ma Y; Wu C; Shi H
BMC Pulm Med; 2024 Jan; 24(1):13. PubMed ID: 38178079
[TBL] [Abstract][Full Text] [Related]
55. A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study.
Tao M; Luo S; Wang X; Jia M; Lu X
Front Endocrinol (Lausanne); 2022; 13():850457. PubMed ID: 35663321
[TBL] [Abstract][Full Text] [Related]
56. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract][Full Text] [Related]
57. Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.
Song W; Lv CG; Miao DL; Zhu ZG; Wu Q; Wang YG; Chen L
Eur J Surg Oncol; 2018 Oct; 44(10):1657-1665. PubMed ID: 30082175
[TBL] [Abstract][Full Text] [Related]
58. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
Front Public Health; 2022; 10():884349. PubMed ID: 35712294
[TBL] [Abstract][Full Text] [Related]
59. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
60. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
